The Effect of Combined Calcium and Vitamin D3 Supplementation on Serum Intact Parathyroid Hormone in Moderate CKD

American Journal of Kidney Diseases

Volumn 53, Issue 3, 2009, Pages 408-416

  Kooienga, Laura ^a   Fried, Linda ^b   Scragg, Robert ^c   Kendrick, Jessica ^a   Smits, Gerard ^a   Chonchol, Michel ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

chronic kidney disease; secondary hyperparathyroidism; Vitamin D3

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE PLUS VITAMIN D 3; COLECALCIFEROL; PARATHYROID HORMONE; PLACEBO; UNCLASSIFIED DRUG; VITAMIN;

ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; ELDERLY CARE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; PARATHYROID HORMONE BLOOD LEVEL; POST HOC ANALYSIS; THERAPY EFFECT; VITAMIN SUPPLEMENTATION;

AGED, 80 AND OVER; CALCIUM, DIETARY; CHOLECALCIFEROL; CHRONIC DISEASE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY DISEASES; PARATHYROID HORMONE; SEVERITY OF ILLNESS INDEX; VITAMINS;

EID: 60149095573     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.09.020     Document Type: Article

References (30)

1. Wolf M., Shah A., Guiterrez O., et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72 (2007) 1004-1013
2. Del Valle E., Negri A.L., Aguirre C., Fradinger E., and Zanchetta J.R. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 11 (2007) 315-321
3. Saab G., Young D.O., Gincherman Y., Giles Y., Norwood K., and Coyne D.W. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 105 (2007) c132-c138
4. LaClair R.E., Hellman R.N., Karp S.L., et al. Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States. Am J Kidney Dis 45 (2005) 1026-1033
5. González E.A., Sachdeva A., Oliver D.A., and Martin K.J. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24 (2004) 503-510
6. Khan S. Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease. Am J Med Sci 333 (2007) 201-207
7. Sadlier D.M., and Magee C.C. Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: A prospective study. Clin Transplant 21 (2007) 683-688
8. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., et al. Hypovitaminosis D in medical inpatients. N Engl J Med 338 (1998) 777-783
9. Dawson-Hughes B., Harris S.S., and Dallal G.E. Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 65 (1997) 67-71
10. Levin A., Bakris G.L., Molitch M., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 71 (2007) 31-38
11. Teng M., Wolf M., Lowrie E., Ofsthun N., Lazarus J.M., and Thadhani R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349 (2003) 446-456
12. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42 suppl 3 (2003) S1-S201
13. 3 supplementation in elderly women: Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: The DECALYOS II Study. Osteoporos Int 13 (2002) 257-264
14. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
15. Charytan C., Coburn J.W., Chonchol M., et al. Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am J Kidney Dis 46 (2005) 58-67
16. Coyne D., Acharya M., Qiu P., et al. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 47 (2006) 263-276
17. Ross E.A., Tian J., Abbound H., et al. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. Am J Nephrol 28 (2008) 97-106
18. Chevalley T., Rizzoli R., Nydegger V., et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos Int 4 (1994) 245-252
19. Li Y.C., Amling M., Pirro A.E., et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139 (1998) 4391-4396
20. Liu Y.L., Lin H.H., Yu C.C., et al. A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients. Ren Fail 28 (2006) 701-707
21. Zhu K., Devine A., Dick I.M., Wilson S.G., and Prince R.L. Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: A five-year randomized controlled trial. J Clin Endocrinol Metab 93 (2008) 743-749
22. 3) therapy and vitamin D insufficiency in patients with chronic kidney disease: A randomized controlled pilot study. Endocr Pract 14 (2008) 10-17
23. DeVille J., Thorp M.L., Tobin L., Gray E., Johnson E.S., and Smith D.H. Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. Nephrology 11 (2006) 555-559
24. Al-Aly Z., Qazi R.A., González E.A., Zeringue A., and Martin K.J. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 50 (2007) 59-68
25. Zisman A.L., Hristova M., Ho L.T., and Sprague S.M. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 27 (2007) 36-43
26. Holick M.F., Matsuoka L.Y., and Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet 2 (1989) 1104-1105
27. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
28. Dusso A.S., Brown A.J., and Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 289 (2005) F8-F28
29. Ritter C.S., Armbrecht H.J., Slatopolsky E., and Brown A.J. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 70 (2006) 654-659
30. Verhave J.C., Fesler P., Ribstein J., du Cailar G., and Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index. Am J Kidney Dis 46 (2005) 233-241